Complete radiological response of an initially locally advanced unresectable pancreatic cancer to chemoradiotherapy using FOLFIRINOX regimen: Report of a case

被引：3
|
作者：
Turner, Kathleen [1 ]
Sandri, Giovanni Battista Levi [1 ]
Boucher, Eveline [2 ,4 ]
Henno, Sebastien [3 ]
Le Prise, Elisabeth [2 ]
Meunier, Bernard [1 ]
Boudjema, Karim [1 ,4 ]
Sulpice, Laurent [1 ,4 ]
机构：
[1] Univ Rennes 1, CHU Rennes, Serv Chirurg Hepatobiliaire & Digest, F-35033 Rennes, France
[2] Univ Rennes 1, Ctr Reg Lutte Canc, F-35042 Rennes, France
[3] Univ Rennes 1, CHU Rennes, Serv Anat & Cytol Pathol, F-35033 Rennes, France
[4] Univ Rennes 1, INSERM, UMR991, Liver Metab & Canc, F-35033 Rennes, France
来源：
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY | 2015年 / 39卷 / 02期
关键词：
OUTCOMES; CHEMOTHERAPY; GEMCITABINE;
D O I：
10.1016/j.clinre.2014.08.011
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：E29 / E31
页数：3
相关论文
共 50 条
  • [41] concurrent chemoradiotherapy using photon and proton for locally advanced pancreatic cancer
    Hiroshima, Y.
    Fukumitsu, N.
    Ishida, T.
    Nakamura, M.
    Shimizu, S.
    Sekino, Y.
    Miyauchi, D.
    Iizumi, T.
    Miura, K.
    Kanuma, R.
    Tanaka, K.
    Saito, T.
    Takizawa, D.
    Numajiri, H.
    Onishi, K.
    Mizumoto, M.
    Aihara, T.
    Ishikawa, H.
    Okumura, T.
    Tsuboi, K.
    Sakurai, H.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S397 - S398
  • [42] Outcomes of FOLFIRINOX (FFX) and gemcitabine plus nab-paclitaxel (GnP) in initially unresectable locally advanced pancreatic cancer (uLAPC): A population-based study.
    Chan, Kelvin K.
    Guo, Helen
    Beca, Jaclyn Marie
    Redmond-Misner, Ruby
    Isaranuwatchai, Wanrudee
    Qiao, Lucy
    Earle, Craig
    Berry, Scott R.
    Biagi, James Joseph
    Welch, Stephen
    Meyers, Brandon
    Mittmann, Nicole
    Coburn, Natalie
    Pardhan, Aliya
    Arias, Jessica
    Gavura, Scott
    Kennedy, Erin Diane
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [43] Tolerability and efficacy of modified FOLFIRINOX (mFOLFIRINOX) in patients with borderline-resectable pancreatic cancer (BRPC) and locally advanced unresectable pancreatic cancer (LAURPC)
    Blazer, Marlo A.
    Wu, Christina Sing-Ying
    Goldberg, Richard M.
    Phillips, Gary S.
    Schmidt, Carl Richard
    Muscarella, Peter
    El-Dika, Samer S.
    Walker, Jon P.
    Krishna, Somashekar Gopala
    Groce, J. Royce
    Wuthrick, Evan John
    Williams, Terence M.
    Efries, David
    Smith, Yahna T.
    Mathey, Kris
    Wagner, Mandy
    Reardon, Josh
    Ellison, Edwin Christopher
    Bloomston, Mark
    Bekaii-Saab, Tanios S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [44] Chemoradiotherapy versus gemcitabine-based chemotherapy in patients with unresectable, locally advanced pancreatic cancer.
    Nio, K.
    Ueno, H.
    Okusaka, T.
    Morizane, C.
    Hagihara, A.
    Kondo, S.
    Mayahara, H.
    Ito, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study
    Passardi, Alessandro
    Scarpi, Emanuela
    Neri, Elisa
    Parisi, Elisabetta
    Ghigi, Giulia
    Ercolani, Giorgio
    Gardini, Andrea
    La Barba, Giuliano
    Pagan, Flavia
    Casadei-Gardini, Andrea
    Valgiusti, Martina
    Ferroni, Fabio
    Frassineti, Giovanni Luca
    Romeo, Antonino
    CANCERS, 2019, 11 (05)
  • [46] Chemoradiotherapy versus chemotherapy for locally advanced unresectable pancreatic cancer: A systematic review and meta-analysis
    Ng, Ivy Weishan
    Soon, Yu Yang
    Chen, Desiree
    Tey, Jeremy Chee Seong
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (06) : 392 - 401
  • [47] Concurrent Chemoradiotherapy Versus Chemotherapy Alone for Unresectable Locally Advanced Pancreatic Cancer: A Retrospective Cohort Study
    Choi, Younak
    Oh, Do-Youn
    Kim, Kyubo
    Chie, Eui Kyu
    Kim, Tae-Yong
    Lee, Kyung-Hun
    Han, Sae-Won
    Im, Seock-Ah
    Kim, Tae-You
    Ha, Sung Whan
    Bang, Yung-Jue
    CANCER RESEARCH AND TREATMENT, 2016, 48 (03): : 1045 - 1055
  • [48] Pancreas resection for unresectable locally advanced pancreatic cancer (LAPC): Resection rate in the era of FOLFIRINOX and GEM plus nabPTX
    Takahashi, Shinichiro
    Ikeda, Masafumi
    Gotohda, Naoto
    Kato, Yuichiro
    Konishi, Masaru
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [49] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer.
    Yamada, Suguru
    Fujii, Tsutomu
    Takano, Nao
    Takami, Hideki
    Suenaga, Masaya
    Niwa, Yukiko
    Hayashi, Masamichi
    Iwata, Naoki
    Kanda, Mitsuro
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Koike, Masahiko
    Fujiwara, Michitaka
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [50] FOLFIRINOX-based neoadjuvant chemoradiotherapy for borderline and locally advanced pancreatic cancer: A pilot study from a tertiary centre
    Pouypoudat, Claudia
    Buscail, Etienne
    Cossin, Sebastien
    Cassinotto, Christophe
    Terrebonne, Eric
    Blanc, Jean-Frederic
    Smith, Denis
    Marty, Marion
    Dupin, Charles
    Laurent, Christophe
    Dabernat, Sandrine
    Chiche, Laurence
    Vendrely, Veronique
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (07) : 1043 - 1049
12345